The AXL Receptor Is a Sensor of Ligand Spatial Heterogeneity

Cell Systems

Volumn 1, Issue 1, 2015, Pages 25-36

  Meyer, Aaron S ^a,b   Zweemer, Annelien J M ^a,b   Lauffenburger, Douglas A ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b Massachusetts Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AXL RECEPTOR; GROWTH ARREST SPECIFIC PROTEIN 6; LIGAND; PHOSPHATIDYLSERINE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SIMULATION;

EID: 84938406332     PISSN: 24054712     EISSN: 24054720     Source Type: Journal    
DOI: 10.1016/j.cels.2015.06.002     Document Type: Article

References (49)

1. C. Audet, V. Béchard, and S. Le Digabel Nonsmooth optimization through Mesh Adaptive Direct Search and Variable Neighborhood Search J. Glob. Optim. 41 2008 299 318
2. S. Bhattacharyya, A. Zagórska, E.D. Lew, B. Shrestha, C.V. Rothlin, J. Naughton, M.S. Diamond, G. Lemke, and J.A. Young Enveloped viruses disable innate immune responses in dendritic cells by direct activation of TAM receptors Cell Host Microbe 14 2013 136 147
3. L. Bosurgi, J.H. Bernink, V. Delgado Cuevas, N. Gagliani, L. Joannas, E.T. Schmid, C.J. Booth, S. Ghosh, and C.V. Rothlin Paradoxical role of the proto-oncogene Axl and Mer receptor tyrosine kinases in colon cancer Proc. Natl. Acad. Sci. USA 110 2013 13091 13096
4. I. Bozic, J.G. Reiter, B. Allen, T. Antal, K. Chatterjee, P. Shah, Y.S. Moon, A. Yaqubie, N. Kelly, D.T. Le, and et al. Evolutionary dynamics of cancer in response to targeted combination therapy eLife 2 2013 e00747
5. T. Burstyn-Cohen, E.D. Lew, P.G. Través, P.G. Burrola, J.C. Hash, and G. Lemke Genetic dissection of TAM receptor-ligand interaction in retinal pigment epithelial cell phagocytosis Neuron 76 2012 1123 1132
6. E.A. Carrera Silva, P.Y. Chan, L. Joannas, A.E. Errasti, N. Gagliani, L. Bosurgi, M. Jabbour, A. Perry, F. Smith-Chakmakova, D. Mucida, and et al. T cell-derived protein S engages TAM receptor signaling in dendritic cells to control the magnitude of the immune response Immunity 39 2013 160 170
7. J.B. Casaletto, and A.I. McClatchey Spatial regulation of receptor tyrosine kinases in development and cancer Nat. Rev. Cancer 12 2012 387 400
8. W.W. Chen, B. Schoeberl, P.J. Jasper, M. Niepel, U.B. Nielsen, D.A. Lauffenburger, and P.K. Sorger Input-output behavior of ErbB signaling pathways as revealed by a mass action model trained against dynamic data Mol. Syst. Biol. 5 2009 239
9. Y. Chen, H. Wang, N. Qi, H. Wu, W. Xiong, J. Ma, Q. Lu, and D. Han Functions of TAM RTKs in regulating spermatogenesis and male fertility in mice Reproduction 138 2009 655 666
10. R.S. Cook, K.M. Jacobsen, A.M. Wofford, D. DeRyckere, J. Stanford, A.L. Prieto, E. Redente, M. Sandahl, D.M. Hunter, K.E. Strunk, and et al. MerTK inhibition in tumor leukocytes decreases tumor growth and metastasis J. Clin. Invest. 123 2013 3231 3242
11. S.P. Dormady, X.M. Zhang, and R.S. Basch Hematopoietic progenitor cells grow on 3T3 fibroblast monolayers that overexpress growth arrest-specific gene-6 (GAS6) Proc. Natl. Acad. Sci. USA 97 2000 12260 12265
12. P.D. Dunne, D.G. McArt, J.K. Blayney, M. Kalimutho, S. Greer, T. Wang, S. Srivastava, C.W. Ong, K. Arthur, M. Loughrey, and et al. AXL is a key regulator of inherent and chemotherapy-induced invasion and predicts a poor clinical outcome in early-stage colon cancer Clin. Cancer Res. 20 2014 164 175
13. C. Ekman, J. Stenhoff, and B. Dahlbäck Gas6 is complexed to the soluble tyrosine kinase receptor Axl in human blood J. Thromb. Haemost. 8 2010 838 844
14. A.R. French, and D.A. Lauffenburger Controlling receptor/ligand trafficking: effects of cellular and molecular properties on endosomal sorting Ann. Biomed. Eng. 25 1997 690 707
15. C. Gjerdrum, C. Tiron, T. Høiby, I. Stefansson, H. Haugen, T. Sandal, K. Collett, S. Li, E. McCormack, B.T. Gjertsen, and et al. Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival Proc. Natl. Acad. Sci. USA 107 2010 1124 1129
16. D.K. Graham, T.L. Dawson, D.L. Mullaney, H.R. Snodgrass, and H.S. Earp Cloning and mRNA expression analysis of a novel human protooncogene, c-mer Cell Growth Differ. 5 1994 647 657
17. D.K. Graham, D.B. Salzberg, J. Kurtzberg, S. Sather, G.K. Matsushima, A.K. Keating, X. Liang, M.A. Lovell, S.A. Williams, T.L. Dawson, and et al. Ectopic expression of the proto-oncogene Mer in pediatric T-cell acute lymphoblastic leukemia Clin. Cancer Res. 12 2006 2662 2669
18. P.B. Gupta, C.M. Fillmore, G. Jiang, S.D. Shapira, K. Tao, C. Kuperwasser, and E.S. Lander Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells Cell 146 2011 633 644
19. M.O. Hall, M.S. Obin, A.L. Prieto, B.L. Burgess, and T.A. Abrams Gas6 binding to photoreceptor outer segments requires γ-carboxyglutamic acid (Gla) and Ca(2+) and is required for OS phagocytosis by RPE cells in vitro Exp. Eye Res. 75 2002 391 400
20. I. Hasanbasic, I. Rajotte, and M. Blostein The role of gamma-carboxylation in the anti-apoptotic function of gas6 J. Thromb. Haemost. 3 2005 2790 2797
21. A.C. Hindmarsh, P.N. Brown, K.E. Grant, S.L. Lee, R. Serban, D.E. Shumaker, and C.S. Woodward SUNDIALS: suite of nonlinear and differential/algebraic equation solvers ACM Trans. Math. Softw. 31 2005 363 396
22. S.J. Holland, A. Pan, C. Franci, Y. Hu, B. Chang, W. Li, M. Duan, A. Torneros, J. Yu, T.J. Heckrodt, and et al. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer Cancer Res. 70 2010 1544 1554
23. M. Hutterer, P. Knyazev, A. Abate, M. Reschke, H. Maier, N. Stefanova, T. Knyazeva, V. Barbieri, M. Reindl, A. Muigg, and et al. Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme Clin. Cancer Res. 14 2008 130 138
24. M.S. Kariolis, Y.R. Miao, D.S. Jones 2nd, S. Kapur, I.I. Mathews, A.J. Giaccia, and J.R. Cochran An engineered Axl 'decoy receptor' effectively silences the Gas6-Axl signaling axis Nat. Chem. Biol. 10 2014 977 983
25. H.-D. Kim, A.S. Meyer, J.P. Wagner, S.K. Alford, A. Wells, F.B. Gertler, and D.A. Lauffenburger Signaling network state predicts twist-mediated effects on breast cell migration across diverse growth factor contexts Mol. Cell. Proteomics 10 2011 M111.008433
26. L.B. Kleiman, T. Maiwald, H. Conzelmann, D.A. Lauffenburger, and P.K. Sorger Rapid phospho-turnover by receptor tyrosine kinases impacts downstream signaling and drug binding Mol. Cell 43 2011 723 737
27. A.B. Lee-Sherick, K.M. Eisenman, S. Sather, A. McGranahan, P.M. Armistead, C.S. McGary, S.A. Hunsucker, J. Schlegel, H. Martinson, C. Cannon, and et al. Aberrant Mer receptor tyrosine kinase expression contributes to leukemogenesis in acute myeloid leukemia Oncogene 32 2013 5359 5368
28. G. Lemke, and C.V. Rothlin Immunobiology of the TAM receptors Nat. Rev. Immunol. 8 2008 327 336
29. E.D. Lew, J. Oh, P.G. Burrola, I. Lax, A. Zagórska, P.G. Través, J. Schlessinger, and G. Lemke Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities eLife 3 2014 3
30. R.M.A. Linger, A.K. Keating, H.S. Earp, and D.K. Graham TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer Adv. Cancer Res. 100 2008 35 83
31. Q. Lu, and G. Lemke Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family Science 293 2001 306 311
32. Q. Lu, M. Gore, Q. Zhang, T. Camenisch, S. Boast, F. Casagranda, C. Lai, M.K. Skinner, R. Klein, G.K. Matsushima, and et al. Tyro-3 family receptors are essential regulators of mammalian spermatogenesis Nature 398 1999 723 728
33. C.S. Monast, C.M. Furcht, and M.J. Lazzara Computational analysis of the regulation of EGFR by protein tyrosine phosphatases Biophys. J. 102 2012 2012 2021
34. T. Nakano, K. Kawamoto, J. Kishino, K. Nomura, K. Higashino, and H. Arita Requirement of gamma-carboxyglutamic acid residues for the biological activity of Gas6: contribution of endogenous Gas6 to the proliferation of vascular smooth muscle cells Biochem. J. 323 1997 387 392
35. M. Paolino, A. Choidas, S. Wallner, B. Pranjic, I. Uribesalgo, S. Loeser, A.M. Jamieson, W.Y. Langdon, F. Ikeda, J.P. Fededa, and et al. The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells Nature 507 2014 508 512
36. D. Prasad, C.V. Rothlin, P. Burrola, T. Burstyn-Cohen, Q. Lu, P. Garcia de Frutos, and G. Lemke TAM receptor function in the retinal pigment epithelium Mol. Cell. Neurosci. 33 2006 96 108
37. I. Rajotte, I. Hasanbasic, and M. Blostein Gas6-mediated signaling is dependent on the engagement of its gamma-carboxyglutamic acid domain with phosphatidylserine Biochem. Biophys. Res. Commun. 376 2008 70 73
38. C.V. Rothlin, S. Ghosh, E.I. Zuniga, M.B.A. Oldstone, and G. Lemke TAM receptors are pleiotropic inhibitors of the innate immune response Cell 131 2007 1124 1136
39. T. Sasaki, P.G. Knyazev, N.J. Clout, Y. Cheburkin, W. Göhring, A. Ullrich, R. Timpl, and E. Hohenester Structural basis for Gas6-Axl signalling EMBO J. 25 2006 80 87
40. R.S. Scott, E.J. McMahon, S.M. Pop, E.A. Reap, R. Caricchio, P.L. Cohen, H.S. Earp, and G.K. Matsushima Phagocytosis and clearance of apoptotic cells is mediated by MER Nature 411 2001 207 211
41. J. Stenhoff, B. Dahlbäck, and S. Hafizi Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts Biochem. Biophys. Res. Commun. 319 2004 871 878
42. T.N. Stitt, G. Conn, M. Gore, C. Lai, J. Bruno, C. Radziejewski, K. Mattsson, J. Fisher, D.R. Gies, P.F. Jones, and et al. The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases Cell 80 1995 661 670
43. J.J. Tabor, H.M. Salis, Z.B. Simpson, A.A. Chevalier, A. Levskaya, E.M. Marcotte, C.A. Voigt, and A.D. Ellington A synthetic genetic edge detection program Cell 137 2009 1272 1281
44. K. Tanabe, K. Nagata, K. Ohashi, T. Nakano, H. Arita, and K. Mizuno Roles of γ-carboxylation and a sex hormone-binding globulin-like domain in receptor-binding and in biological activities of Gas6 FEBS Lett. 408 1997 306 310
45. S. Thomson, F. Petti, I. Sujka-Kwok, P. Mercado, J. Bean, M. Monaghan, S.L. Seymour, G.M. Argast, D.M. Epstein, and J.D. Haley A systems view of epithelial-mesenchymal transition signaling states Clin. Exp. Metastasis 28 2011 137 155
46. W.-I. Tsou, K.-Q.N. Nguyen, D.A. Calarese, S.J. Garforth, A.L. Antes, S.V. Smirnov, S.C. Almo, R.B. Birge, and S.V. Kotenko Receptor tyrosine kinases, TYRO3, AXL and MER, demonstrate distinct patterns and complex regulation of ligand-induced activation J. Biol. Chem. 289 2014 25750 25763
47. M. Yanagita, K. Ishii, H. Ozaki, H. Arai, T. Nakano, K. Ohashi, K. Mizuno, T. Kita, and T. Doi Mechanism of inhibitory effect of warfarin on mesangial cell proliferation J. Am. Soc. Nephrol. 10 1999 2503 2509
48. Y.X. Zhang, P.G. Knyazev, Y.V. Cheburkin, K. Sharma, Y.P. Knyazev, L. Orfi, I. Szabadkai, H. Daub, G. Kéri, and A. Ullrich AXL is a potential target for therapeutic intervention in breast cancer progression Cancer Res. 68 2008 1905 1915
49. Z. Zhang, J.C. Lee, L. Lin, V. Olivas, V. Au, T. LaFramboise, M. Abdel-Rahman, X. Wang, A.D. Levine, J.K. Rho, and et al. Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer Nat. Genet. 44 2012 852 860